Live Science on MSN
An experimental mRNA treatment counters immune cell aging in mice
A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds.
Morning Overview on MSN
Experimental mRNA therapy reverses immune-cell aging in mice
Researchers have used an experimental mRNA therapy to make old immune cells in mice behave as if they were young again, ...
An analysis of ongoing trials suggests that mRNA cancer vaccines have the potential to deliver health benefits worth $75 ...
Researchers found a way to boost aging immune systems by turning the liver into a temporary source of immune support signals ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA ...
News-Medical.Net on MSN
mRNA therapy rejuvenates immune function in aging mice
Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ), the HI-STEM institute, and the Broad Institute have demonstrated that ...
16don MSN
Moderna receives $54.3M investment for bird flu vaccine, covering axed federal mRNA contracts
Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...
StockStory.org on MSN
Moderna (MRNA) Stock Trades Up, Here Is Why
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the afternoon session after the broader biotech sector experienced a strong rebound, lifting shares of companies within the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results